1888PressRelease.com

Biogenum.com - Biogenum Company News Section

Biogenum Press Release -

Biogenum.com

Biogenum Appoints Kang Tae-suk as Senior Vice President, Head of Regulatory Affairs
Mr. Kang Tae-suk will be also responsible of the advancement of BGM-27 and Tau NonTangles™ into the market after Phase I of the project.
December 09, 2019

Biogenum Funds Expansion of Cognition Study in Running Birth Cohort
The company is currently investing in more than 58 active best-of-field projects in 7 countries.
December 09, 2019

Biogenum Presents Data on Symptom Improvement by BGM-27 Immunotherapy Targeting pTau on Negative Symptoms, Depression, and Social Function in Patients with Alzheimer
The data will be presented at the Asian Society of Alzheimer Prevention (ASAP) Annual Meeting.
December 09, 2019

Biogenum Presents Periodic Corporate Update
The company reveals the addition of new senior team members and drugs development status.
December 09, 2019

Biogenum Receives $1 Million Grant to Enhance Psychosocial Research for Dementia Care
The grant marks the first time the company receives direct funding as principal investigator in a research study.
December 07, 2019